STERIS Price to Sales Ratio 2010-2022 | STE
Historical PS ratio values for STERIS (STE) over the last 10 years. The current P/S ratio for STERIS as of January 27, 2023 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| STERIS P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2023-01-27 |
206.10 |
|
4.31 |
| 2022-09-30 |
165.84 |
$47.79 |
3.47 |
| 2022-06-30 |
205.12 |
$47.67 |
4.30 |
| 2022-03-31 |
240.07 |
$46.83 |
5.13 |
| 2021-12-31 |
241.24 |
$44.69 |
5.40 |
| 2021-09-30 |
202.09 |
$42.10 |
4.80 |
| 2021-06-30 |
203.68 |
$39.02 |
5.22 |
| 2021-03-31 |
187.67 |
$36.19 |
5.19 |
| 2020-12-31 |
186.31 |
$35.63 |
5.23 |
| 2020-09-30 |
172.83 |
$35.27 |
4.90 |
| 2020-06-30 |
150.12 |
$35.06 |
4.28 |
| 2020-03-31 |
136.60 |
$35.39 |
3.86 |
| 2019-12-31 |
148.43 |
$34.77 |
4.27 |
| 2019-09-30 |
140.36 |
$33.88 |
4.14 |
| 2019-06-30 |
144.26 |
$33.22 |
4.34 |
| 2019-03-31 |
123.76 |
$32.55 |
3.80 |
| 2018-12-31 |
102.99 |
$31.92 |
3.23 |
| 2018-09-30 |
109.94 |
$31.49 |
3.49 |
| 2018-06-30 |
100.62 |
$30.93 |
3.25 |
| 2018-03-31 |
89.20 |
$30.55 |
2.92 |
| 2017-12-31 |
83.29 |
$30.11 |
2.77 |
| 2017-09-30 |
83.88 |
$29.95 |
2.80 |
| 2017-06-30 |
77.05 |
$30.05 |
2.56 |
| 2017-03-31 |
65.44 |
$30.34 |
2.16 |
| 2016-12-31 |
63.23 |
$32.13 |
1.97 |
| 2016-09-30 |
68.31 |
$32.52 |
2.10 |
| 2016-06-30 |
63.99 |
$33.15 |
1.93 |
| 2016-03-31 |
65.89 |
$33.07 |
1.99 |
| 2015-12-31 |
69.60 |
$31.73 |
2.19 |
| 2015-09-30 |
60.02 |
$31.63 |
1.90 |
| 2015-06-30 |
59.53 |
$31.23 |
1.91 |
| 2015-03-31 |
64.92 |
$30.83 |
2.11 |
| 2014-12-31 |
59.91 |
$30.26 |
1.98 |
| 2014-09-30 |
49.85 |
$29.19 |
1.71 |
| 2014-06-30 |
49.41 |
$27.90 |
1.77 |
| 2014-03-31 |
44.11 |
$27.15 |
1.62 |
| 2013-12-31 |
44.39 |
$26.64 |
1.67 |
| 2013-09-30 |
39.50 |
$26.30 |
1.50 |
| 2013-06-30 |
39.23 |
$25.94 |
1.51 |
| 2013-03-31 |
37.91 |
$25.57 |
1.48 |
| 2012-12-31 |
31.49 |
$24.91 |
1.26 |
| 2012-09-30 |
31.98 |
$24.56 |
1.30 |
| 2012-06-30 |
28.13 |
$24.27 |
1.16 |
| 2012-03-31 |
28.18 |
$23.79 |
1.18 |
| 2011-12-31 |
26.44 |
$23.45 |
1.13 |
| 2011-09-30 |
25.80 |
$22.81 |
1.13 |
| 2011-06-30 |
30.65 |
$22.24 |
1.38 |
| 2011-03-31 |
30.13 |
$20.12 |
1.50 |
| 2010-12-31 |
31.66 |
$19.43 |
1.63 |
| 2010-09-30 |
28.73 |
$19.46 |
1.48 |
| 2010-06-30 |
26.74 |
$19.56 |
1.37 |
| 2010-03-31 |
28.86 |
$21.20 |
1.36 |
| 2009-12-31 |
23.90 |
$21.40 |
1.12 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$20.456B |
$4.585B |
|
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
|
